Biomea Fusion Inc.

12/17/2024 | Press release | Distributed by Public on 12/17/2024 07:10

Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes